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A Courtroom Diagnosis:
Countering the Defense of
Temporary Brittle Bone Disease
and Mild OI
By Joëlle Anne Moreno, J.D.1

In child abuse cases involving multiple fractures,
prosecutors and investigators are increasingly facing a
relatively new defense. In some jurisdictions, judges are
allowing defense medical experts to testify that infants
have not been abused, but instead suffer from a mild
form of Osteogenesis Imperfecta (OI) or a purported
variant of OI, Temporary Brittle Bone Disease (TBBD).
These diagnoses are offered in cases where the injuries
are highly specific for abuse because they involve: (1)
fractures typical of abuse in different stages of healing;
(2) infants who have tested negative for conventionally
diagnosable metabolic bone diseases (including OI); and
(3) infants whose bones do not continue to fracture after
they are placed in protective custody. 2
It is critically important for doctors, investigators and
prosecutors to be able to distinguish bone disease from
abuse because OI is the most frequent medical/legal
defense in suspected cases of child abuse.3 This article
will provide a brief and general overview of what is
currently known and accepted in the medical literature
about OI, and then examine more controversial
diagnoses such as TBBD. Finally, strategies for
prosecutors will be discussed for dealing with bone
disease defenses.

What is Osteogenesis Imperfecta?

Osteogenesis imperfecta (OI) is a genetic disorder
characterized by bone fragility and frequent fractures.
It is described in the medical literature as an “inherited
disorder of connective tissue with deficiency of type I
collagen leading to abnormal bone formation and
increased bone fragility. As a result, trivial or
unobserved injuries may cause fractures in those
patients.”4 OI is extremely rare. The incidence is
estimated to be between 1 in 15,000 to 1 in 60,000
births.5#
OI is classified into four major types, depending on the
age of onset of fractures, extraskeletal manifestations,
and mode of inheritance.6 Infants suffering from OI
types I and II, who account for 80 percent of all cases of
OI, have obvious clinical manifestations, such as blue
sclera (the white area of the eye looks blue). In
addition, OI type II is almost invariably lethal in the
perinatal or neonatal period (causing death in the womb
or shortly after birth).7 Of the remaining 20 percent of
children who suffer from OI (types III and IV), those
who have type III typically have wormian bones (a
haphazard suturelike pattern seen on certain bone
surfaces) and osteoporosis (fragile, porous bones).
These bone abnormalities should be easily detected
using radiologic tests. 8
The readily identifiable features of OI types I, II, and III
enhance the likelihood that physicians examining a
patient for OI can make an accurate diagnosis. Thus,
only OI type IV, a mild form of the disease, might be
confused with child abuse. However, even OI type IV
has certain clinical indicators that experts can use to
ensure a valid diagnosis.
“Patients with OI type IV have variable degrees of short
stature, with mild to moderate deformity. Fractures may
begin to occur prenatally and may be associated with
deformity of the long bones that is evident at birth. . . .
Affected patients generally have a triangular head, with
a prominent forehead. Sclera are generally normal,
except in infancy, when they have a blue hue. . . .
Radiologic examination demonstrates osteoporosis, mild
to severe bowing of the long bones, and spinal
deformity. 9”
Prosecutors can use this medical information to argue
that it is “generally uncomplicated to distinguish OI from
child abuse.”10 One recent study “calculated the
probability of encountering a child under one year of age
with OI and no other features or family findings of the
disease as between 1 in 1 million and one in 3 million,
or an annual incidence of one case every 100 to 300
years in a city of half a million people.”11

Judges deciding whether to admit a defense diagnosis of
a variant form of OI or TBBD must assess the likelihood
that a child would suffer from this disorder, but have no
signs or symptoms of the disease beyond multiple
fractures. The “likelihood of a clinician seeing a child
with mild type IV OI and with white sclera, normal
hearing, normal dentition [teeth], negative family
history, and no wormian bones is exceedingly rare.” 12
In the words of one medical expert, “[g]iven the rarity
of this type of OI (1:1 to 3 million births), . . . relative
to the frequency of child abuse, the probability of
[diagnostic] error is minimal.”13 This last point is
particularly important for multi disciplinary team (MDT)
members considering the possibility of OI rather than
child abuse. It is commonly accepted that child physical
abuse is vastly under reported. However, the existing
data shows that children age 03 comprise the majority
of abuse victims, and that physical abuse (not including
neglect and sexual abuse) affects at least two to three
children per 1,000 in recent years. 14

What is Temporary Brittle Bone Disease?
The diagnosis of TBBD originated in 1990 at the Fourth
Annual Conference of Osteogenesis Imperfecta. 15 TBBD
is described as a shortlived developmental bone disease
that results in easy bone fracturability in very young
children for a limited period of time. 16 Unchallenged, a
defense of TBBD might explain the existence of fractures
that conflict with a caregiver’s clinical history that
excludes trauma. TBBD presumes that an infant’s bones
will break with routine nonabusive handling. The
assumption that this disease is transient cannot
adequately explain how all fractures stop once the child
is placed in protective custody, when routine handling
obviously continues under protective custody.
It is vitally important that all MDTs know that TBBD is
not a recognized disease. 17 Despite the medical
evidence discrediting TBBD,18 defenses based on this
diagnosis have found a welcome reception in some
courtrooms. Recently the Arizona Supreme Court
concluded that it was an abuse of the trial court’s
discretion to exclude defense expert testimony on TBBD.
19 The court adopted the defense argument that TBBD
was a valid diagnosis and referred to the proffered
expert, Dr. Colin Paterson, as “arguably the world’s
preeminent TBBD expert.”20 However, Dr. Paterson’s
TBBD publications have been challenged by other
medical experts.
For example, in a 1989 article, Dr. Paterson and Dr.
McAllion studied 804 patients who had been diagnosed
with OI.21 The study concluded that although

nonaccidental injury had been suspected in 113 of the
cases (and 18 child abuse investigations initiated), none
of the 804 patients had suffered from abuse.22 This
study has been criticized by a prominent pediatrician
who expressed concern about the lack of diagnostic
criteria in this study 2323 and found that the symptoms
purportedly associated with TBBD looked suspiciously
like the characteristics of child abuse. Specifically,
metaphyseal fractures that occur at the ends of long
bones, vomiting, diarrhea, breathing abnormalities, liver
enlargement, rib fractures and other abnormalities,
which are listed as symptoms of TBBD, are also all
classic signs of child abuse and neglect.24 This article
exposes several methodological flaws in the published
medical research that purports to establish the existence
of TBBD.
Prosecutors should also be aware that TBBD has
encountered more strenuous judicial resistance in
England. In 2001, Judge Peter Singer of the Royal Courts
of Justice, Family Division ruled that TBBD expert
testimony was not only inadmissable, but also
scientifically invalid citing “the subjectivity, the
unreliability, the unscientific and unproved nature of Dr.
Paterson’s speculations that TBBD exists as a clinical
entity.” 25

Challenging Medical Testimony on TBBD
and Mild OI
Testimony about unorthodox and unproven diagnoses
like TBBD or mild OI can be challenged on their validity
and a lack of acceptance in the general medical
community under Frye26 or Daubert27 standards. The
first step is to persuade the judge to put the defense
diagnosis in context. This requires a fundamental
understanding of OI, its recognized forms and its
diagnostic criteria. Prosecutors can use this medical
information to educate judges about the difference
between a diagnosis of a recognized type of OI and a
diagnosis of a variant form of OI or TBBD, which often
lack both diagnostic criteria and valid empirical support.
In the event that the evidence is admitted over
prosecution objection, this medical evidence should form
the basis of an effective crossexamination.
OI can be diagnosed with a high degree of medical
certainty based on radiographic testing, family history,
and in rare cases a collagen test. When the patient lacks
clinical signs and has tested negative for OI, prosecutors
should be ready to probe defenses based on variant
forms of OI, including TBBD. These disorders have not
been accepted by the general medical community, and
their underlying theory and diagnostic methodologies

have been criticized by recognized experts in the field.
Whenever a bone disease defense is raised, prosecutors
should consider the surrounding circumstances, evaluate
the medical evidence, and employ common sense and
simple logic. Has the child suffered any further fractures
since being removed from the suspect’s care? Are these
fractures highly specific for abuse (such as metaphyseal
fractures where the bone flares, rather than long bone
fractures)? Are the fractures unlikely to be caused by
routine handling (even of a child who does suffer from a
boneweakening disease)? 28 Working together, MDT
members can help differentiate abuse from recognized
illness and prevent judges and jurors from using
improper and unfounded scientific testimony to decide
child abuse cases.
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